Azithromycin vs Roflumilast for AECOPD
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
A UCLA Health study compared azithromycin and roflumilast in protecting against acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Read MoreUCLA study finds that small cell neuroendocrine tumors depend on a specific protein to grow, offering a potential path for new treatments.
Read MoreUCLA Health detected and halted a rare strain of Pseudomonas aeruginosa that carries a gene called NDM-1, or New Delhi metallo-β-lactamase.
Read MoreWhat is Long COVID? Despite hundreds of published studies and millions affected worldwide, the medical field still lacks a clear answer.
Read MoreMore than half the patients being admitted to the ICU could have been cared for in less expensive and invasive settings, researchers say.
Read More